Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2
- PMID: 34153162
- PMCID: PMC8441800
- DOI: 10.1111/ajt.16726
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2
Keywords: clinical research/practice; immunosuppressant; immunosuppression/immune modulation; infection and infectious agents - viral; infectious disease; kidney transplantation/nephrology; vaccine.
Comment on
-
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.Am J Transplant. 2021 Aug;21(8):2719-2726. doi: 10.1111/ajt.16615. Epub 2021 May 7. Am J Transplant. 2021. PMID: 33866672 Free PMC article.
References
-
- World Health Organization. Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-f.... Updated May 12, 2021. Accessed June 9, 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous